Allergenis (Equity)
Funding Details
- Awarder
- StartEngine
- Date Award
- June 13, 2024
- Vertical
- Healthcare
- Funding URL
- View Funding Page
- Premoney Valuation
- $40,000,000
- Valuation
- $40,000,000
- Funding Amount:
- $547,923,660,000
Company Info
- Founding Year
- 2023
- Traction
- Allergenis has a patent-protected food allergy diagnostic platform with 93% accuracy, targeting the growing food allergy market. They have partnered with global therapeutic companies and have a strong team with a track record of success in diagnostic product development.
- Revenue Amount
- $74,140,000,000
- Organizations Involved
- Mount Sinai Innovation Partners (MSIP)
- Founders
- James A. Garner, Albert A. Luderer, Hugh A. Sampson
- Company Description
- Allergenis is a develops precision, data-driven diagnostics to help healthcare providers more accurately and safely diagnose food allergy.
- Market
- Food Allergy Testing
- Location
- New York, NY, US
- Coinvestors
- None